Supplementary Table 2
Supplementary Table 2
Supplementary Table 1: Selection of candidate genes in single
Supplementary Table 1: Selected DNA repair targeted therapies
Supplementary Table 1: Known human polymorphisms for efficacy
Supplementary Table 1: Characteristics of 45 case
Supplementary Table 1. Ostensible explanations and potential
Supplementary Table 1. Messenger RNA expression selected
Supplementary Table 1. List of reorganized
Supplementary table 1. Expression of CIP2A and MYC in 20
Supplementary Table 1, Supplementary Methods, and
Supplementary Table 1 and 2 (doc 92K)
Supplementary Table 1 - Clinical Cancer Research
Supplementary Table 1
Supplementary Table (doc 548K)
Supplementary section (doc 26K)
Supplementary Results and Figures (doc 1347K)
Supplementary references (for website)
Supplementary methods, legends and Table S1
Supplementary methods for:
